VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

Swiss National Bank's Holding History (CIK: 0001582202)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 110,200 Value ($000) $1,238 Avg Close — Range —
Q1 2025
Shares 123,100 Value ($000) $563 Avg Close — Range —
Q4 2024
Shares 133,100 Value ($000) $751 Avg Close — Range —
Q3 2024
Shares 115,100 Value ($000) $557 Avg Close — Range —
Q2 2024
Shares 115,100 Value ($000) $562 Avg Close — Range —
Q1 2024
Shares 103,200 Value ($000) $1,370 Avg Close — Range —
Q4 2023
Shares 108,500 Value ($000) $1,512 Avg Close — Range —
Q3 2023
Shares 95,300 Value ($000) $1,264 Avg Close — Range —
Q2 2023
Shares 87,600 Value ($000) $1,643 Avg Close — Range —
Q1 2023
Shares 73,100 Value ($000) $1,054 Avg Close — Range —
Q4 2022
Shares 79,600 Value ($000) $1,540 Avg Close — Range —
Q3 2022
Shares 76,300 Value ($000) $2,621 Avg Close — Range —
Q2 2022
Shares 45,400 Value ($000) $694 Avg Close — Range —
Q1 2022
Shares 39,900 Value ($000) $911 Avg Close — Range —
Q4 2021
Shares 36,900 Value ($000) $1,361 Avg Close — Range —